Holen Sie sich die Stockscreener-App
11.85
2.95%
-0.36
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
Avoiding Lag: Real-Time Signals in (MDWD) Movement - Stock Traders Daily
Mediwound Ltd Ord Sh (MDWD-Q) Stock Price and News - The Globe and Mail
Weekly Recap: DoD funding for NexoBrid and VALUE Phase III reassessment - TradingView
TD Cowen reiterates MediWound stock rating ahead of trial data By Investing.com - Investing.com Canada
TD Cowen reiterates MediWound stock rating ahead of trial data By Investing.com - Investing.com Australia
TD Cowen reiterates MediWound stock rating ahead of trial data - Investing.com
MediWound Ltd. (MDWD) Stock Price, News, Quote & History - Yahoo! Finance Canada
MediWound Ltd. Receives Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid - marketscreener.com
MDWD Looks 11.4% Overvalued on GF Value™ - GuruFocus
Understanding the Setup: (MDWD) and Scalable Risk - Stock Traders Daily
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) - benzinga.com
MediWound receives $3.3M from DoD for NexoBrid development By Investing.com - Investing.com Canada
MediWound receives $3.3M from DoD for NexoBrid development - Investing.com
MediWound receives $3.3M from DoD for NexoBrid development By Investing.com - Investing.com Nigeria
MediWound Awarded Additional $3.3 Million from U.S. - GlobeNewswire
MediWound Awarded Additional $3.3 Million from U.S. - GlobeNewswire
A $21.8M program is developing burn care that can stay at room temperature - Stock Titan
MediWound Awarded Additional $3.3 Million from U.S. - globenewswire.com
MediWound Awarded Additional $3.3 Million from U.S. Department of War to Advance Room-Temperature-Stable Formulation of NexoBrid® - Yahoo Finance
Why the Pentagon Keeps Funding This Small Cap (Nasdaq: MDWD) - TradingView
TD Cowen Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification - Yahoo Finance
Reviewers found no safety concerns in MediWound's wound trial. - stocktitan.net
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification - GlobeNewswire
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Director of MediWound (NASDAQ: MDWD) trades shares via spouse - stocktitan.net
An FDA-approved burn treatment company’s CEO will join a New York fireside chat. - stocktitan.net
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
Hungarian fund owns double-digit MediWound (MDWD) stake - stocktitan.net
MediWound (NASDAQ: MDWD) seller Hess plans $50K, 3,958-share sale - stocktitan.net
New Research Estimates a $4 Billion Market by 2028, and MediWound Thinks It May Have a Solution (Nasdaq - Benzinga
MediWound (MDWD) Q2 2026 Earnings Call Transcript - AOL.ca
MediWound (MDWD) Q2 2026 Earnings Call Transcript - AOL.com
MediWound (MDWD) Q2 2026 Earnings Call Transcript - The Globe and Mail
MediWound (MDWD) Q2 2026 Results: The Available Earnings Metric Delivers a Beat in the Current Update; Closing Reaction: The Stock Records a 1.87% Increase in the Current UpdateRevenue Per Share - vinanet.vn
MediWound (MDWD) Q2 2026 Results: The Available Earnings Metric Delivers a Beat in the Current Update; Closing Reaction: The Stock Records a 1.87% Increase in the Current UpdateEarnings Forecast Report - siam.in
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayNegative Surprise Momentum - dars.gov.et
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayProfit Growth Outlook - vinanet.vn
What is HC Wainwright's Forecast for MediWound Q3 Earnings? - MarketBeat
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayCost Structure Review - dars.gov.et
Weekly Recap: Reaffirmed 2026 guidance and EscharEx Phase III enrollment - TradingView
MDWD Looks 30.8% Overvalued on GF Value™ - GuruFocus
MDWD Looks 30.8% Overvalued on GF Value™ - GuruFocus
Mediwound Ltd (MDWD) Stock News Today - TradingKey
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - Moomoo
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - webull.com
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):